Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BeOne Medicines Ltd.

ONC•NASDAQ
Healthcare
Medical - Pharmaceuticals
$370.64
$8.50(2.35%)
U.S. Market opens in 15h 49m

BeOne Medicines Ltd. (ONC) Stock Forecast & Price Predictions

Get the latest BeOne Medicines Ltd. (ONC) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$370.79
Change↑ $0.15 (0.04%)

Quarterly Forecast

Predicted Price$342.97
Change↓ $-27.67 (-7.47%)

Yearly Forecast

Predicted Price$422.04
Change↑ $51.40 (13.87%)

3 Years Forecast

Predicted Price$630.27
Change↑ $259.63 (70.05%)

5 Years Forecast

Predicted Price$837.36
Change↑ $466.72 (125.92%)

7 Years Forecast

Predicted Price$1076.06
Change↑ $705.42 (190.33%)

BeOne Medicines Ltd. Stock Forecast Summary

BeOne Medicines Ltd. (ONC) stock is currently priced at $370.64. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $370.79.

In the long term, ONC shows a bullish trend. The 2027 forecast points to $422.04 (13.87% change), while the 2031 forecast suggests $837.36 (125.92% change). Looking 7 years ahead, projections estimate the stock could trade near $1076.06, a 190.33% change from today’s price.

Overall Sentiment

Bullish

Short-Term Outlook

Bullish

Long-Term Outlook

Bullish

This mix indicates that BeOne Medicines Ltd. stock is expected to rise steadily over the coming years.

BeOne Medicines Ltd. yearly Price Forecast Chart

Explore the yearly forecast chart for ONC, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate BeOne Medicines Ltd. over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for ONCForecasting details for ONC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

BeOne Medicines Ltd. Stock Forecast 2026

The forecast for BeOne Medicines Ltd. (ONC) in 2026 suggests a price of $422.04, representing a 13.87% move from today’s price.

Average Target: $422.04

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

BeOne Medicines Ltd. Stock Forecast 2030

By 2030, Meyka AI projects ONC could trade near $837.36, showing a potential 125.92% compared to current levels.

Average Target: $837.36

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward BeOne Medicines Ltd..

BeOne Medicines Ltd. 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for ONC points to a price around $1076.06, which is a projected 190.33% move from today’s level.

Average Target: $1076.06

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • BeOne Medicines Ltd.’s ability to maintain market leadership.

Frequently Asked Questions